Literature DB >> 24526251

The role of rheumatologists vis-à-vis assessment of traditional cardiovascular risk factors in rheumatoid arthritis.

Yael Luck1, Murray Baron, Sonia Bardakjian, Laeora Berkson, Maura Buchignani, Sabrina Fallavolita, Frédérique Giac, Geneviève Gyger, Solène Tatibouet, Marie Hudson.   

Abstract

This study was designed to estimate the burden of care that would be placed on rheumatologists to undertake cardiovascular (CV) risk assessment of traditional CV risk factors in their patients. This cross-sectional study was set in a rheumatology ambulatory clinic of a tertiary care, university hospital. Consecutive rheumatoid arthritis (RA) patients were recruited over 6 weeks and matched 1:1 on age and sex to patients with non-inflammatory problems who presented to the same clinic. CV risk was calculated using the Framingham Risk Score. We recruited 68 RA patients and 64 controls. The distribution of CV risk factors in RA patients and controls was similar. Ten-year Framingham CV risk scores based on traditional risk factors were moderate and similar in RA patients and controls (13.7 and 14.3%, respectively). Nevertheless, the proportion of RA patients with a history of coronary artery disease was more than twice that of controls (13 versus 5%, respectively). Approximately 20% of RA patients and controls did not have a primary care physician. In rheumatology practice, the problem of elevated CV risk due to traditional risk factors is not unique to RA patients. The burden for rheumatologists of undertaking CV risk assessment in their clinic could be considerable. Rheumatologists should manage inflammatory disease and health services should be improved to ensure the optimal management of traditional CV risk factors for all rheumatology patients.

Entities:  

Mesh:

Year:  2014        PMID: 24526251     DOI: 10.1007/s10067-014-2522-5

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  15 in total

Review 1.  Prevention of cardiovascular disease in systemic lupus erythematosus--proposed guidelines for risk factor management.

Authors:  J Wajed; Y Ahmad; P N Durrington; I N Bruce
Journal:  Rheumatology (Oxford)       Date:  2003-07-16       Impact factor: 7.580

2.  Patterns of cardiovascular risk in rheumatoid arthritis.

Authors:  D H Solomon; N J Goodson; J N Katz; M E Weinblatt; J Avorn; S Setoguchi; C Canning; S Schneeweiss
Journal:  Ann Rheum Dis       Date:  2006-06-22       Impact factor: 19.103

3.  EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis.

Authors:  M J L Peters; D P M Symmons; D McCarey; B A C Dijkmans; P Nicola; T K Kvien; I B McInnes; H Haentzschel; M A Gonzalez-Gay; S Provan; A Semb; P Sidiropoulos; G Kitas; Y M Smulders; M Soubrier; Z Szekanecz; N Sattar; M T Nurmohamed
Journal:  Ann Rheum Dis       Date:  2009-09-22       Impact factor: 19.103

4.  Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors.

Authors:  Cecilia P Chung; Annette Oeser; Paolo Raggi; Tebeb Gebretsadik; Ayumi K Shintani; Tuulikki Sokka; Theodore Pincus; Ingrid Avalos; C Michael Stein
Journal:  Arthritis Rheum       Date:  2005-10

Review 5.  Traditional cardiovascular risk factors, inflammation and cardiovascular risk in rheumatoid arthritis.

Authors:  Katherine P Liao; Daniel H Solomon
Journal:  Rheumatology (Oxford)       Date:  2012-09-16       Impact factor: 7.580

Review 6.  Risk factors for cardiovascular disease in rheumatoid arthritis.

Authors:  Sherine E Gabriel; Cynthia S Crowson
Journal:  Curr Opin Rheumatol       Date:  2012-03       Impact factor: 5.006

7.  Lack of cardiovascular risk assessment in inflammatory arthritis and systemic lupus erythematosus patients at a tertiary care center.

Authors:  Stephanie O Keeling; Michelle Teo; Daisy Fung
Journal:  Clin Rheumatol       Date:  2011-04-19       Impact factor: 2.980

8.  High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors.

Authors:  I D del Rincón; K Williams; M P Stern; G L Freeman; A Escalante
Journal:  Arthritis Rheum       Date:  2001-12

Review 9.  Accelerated atherogenesis in autoimmune rheumatic diseases.

Authors:  P A Bacon; R J Stevens; D M Carruthers; S P Young; G D Kitas
Journal:  Autoimmun Rev       Date:  2002-12       Impact factor: 9.754

Review 10.  Measures of rheumatoid arthritis disease activity: Patient (PtGA) and Provider (PrGA) Global Assessment of Disease Activity, Disease Activity Score (DAS) and Disease Activity Score with 28-Joint Counts (DAS28), Simplified Disease Activity Index (SDAI), Clinical Disease Activity Index (CDAI), Patient Activity Score (PAS) and Patient Activity Score-II (PASII), Routine Assessment of Patient Index Data (RAPID), Rheumatoid Arthritis Disease Activity Index (RADAI) and Rheumatoid Arthritis Disease Activity Index-5 (RADAI-5), Chronic Arthritis Systemic Index (CASI), Patient-Based Disease Activity Score With ESR (PDAS1) and Patient-Based Disease Activity Score without ESR (PDAS2), and Mean Overall Index for Rheumatoid Arthritis (MOI-RA).

Authors:  Jaclyn K Anderson; Lani Zimmerman; Liron Caplan; Kaleb Michaud
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-11       Impact factor: 4.794

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.